Today's Information

Provided by: SYNMOSA BIOPHARMA CORPORATION
SEQ_NO 1 Date of announcement 2022/08/11 Time of announcement 15:54:09
Subject 
 To announces SYNMOSA board of directors has
lifted the restriction on the prohibition of
competition for managerial officer
Date of events 2022/08/11 To which item it meets paragraph 21
Statement 
1.Date of the board of directors resolution:2022/08/11
2.Name and title of the managerial officer with
permission to engage in competitive conduct:
Lin, Chih-Hui/General Manager
3.Items of competitive conduct in which the officer is
permitted to engage:
Serving as a managerial officer、director or supervisor of a company with
the same or similar business scope as the company.
4.Period of permission to engage in the competitive
conduct:
Managerial officer while working as a supervisor of the company.
5.Circumstances of the resolution (please describe the
results of voting in accordance with Article 32 of the
Company Act):
All directors passed without objection.
6.If the permitted competitive conduct belongs to the
operator of a mainland China enterprise, the name and
 title of the managerial officer (if it is not the
operator of a mainland China enterprise, please enter
"N/A" below):N/A
7.Company name of the mainland China enterprise and the
officer's position in the enterprise:N/A
8.Address of the mainland China enterprise:N/A
9.Operations of the mainland China enterprise:N/A
10.Impact on the company's finance and business:none
11.If the managerial officer or director has invested in
 the mainland China enterprise, the monetary amount of the
 investment and the officer or director's shareholding ratio:none
12.Any other matters that need to be specified:none

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Synmosa Biopharma Corporation published this content on 11 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2022 08:00:00 UTC.